Erratum to: Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis

Affiliations

¹ Department of Oncology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 21231, USA.
² Department of Dermatology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, 30322, USA.
³ Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
⁴ Department of Oncology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 21231, USA. dsharma7@jhmi.edu.

Published Erratum

Arumugam Nagalingam et al. Breast Cancer Res. 2017.

. 2017 Mar 28;19(1):39.

doi: 10.1186/s13058-017-0829-2.

¹ Department of Oncology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 21231, USA.
² Department of Dermatology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, 30322, USA.
³ Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
⁴ Department of Oncology, Johns Hopkins University School of Medicine and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 21231, USA. dsharma7@jhmi.edu.

No abstract available

Figures

Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis.
Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D. Nagalingam A, et al. Breast Cancer Res. 2012 Feb 21;14(1):R35. doi: 10.1186/bcr3128. Breast Cancer Res. 2012. PMID: 22353783 Free PMC article.

1. Nagalingam A, et al. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res. 2012;14(1):R35. doi: 10.1186/bcr3128. - DOI - PMC - PubMed